During the past decade, Retina Macula Specialists of Miami conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retina Macula Specialists of Miami" #1 sponsor was "Jaeb Center for Health Research" with 3 trials, followed by "Allergan" with 1 trials sponsored, "Bayer" with 1 trials sponsored, "Nova Southeastern University" with 1 trials sponsored and "Taiwan Liposome Company" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retina Macula Specialists of Miami" #1 collaborator was "Regeneron Pharmaceuticals" with 2 trials as a collaborator, "Carl Zeiss Meditec, Inc." with 1 trials as a collaborator, "Kowa Company, Ltd." with 1 trials as a collaborator, "National Eye Institute (NEI)" with 1 trials as a collaborator and "National Institutes of Health (NIH)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Retina Macula Specialists of Miami" are "Diabetic Macular Edema" (3 trials), "Diabetic Retinopathy" (1 trials), "Macula Edema" (1 trials), "Macular Degeneration" (1 trials) and "Neovascular Age-Related Macular Degeneration" (1 trials). Many other conditions were trialed in "Retina Macula Specialists of Miami" in a lesser frequency.

Most popular intervention types in "Retina Macula Specialists of Miami" are "Drug" (6 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abicipar Pegol" (1 trials), "Aflibercept High Dose VEGF Trap-Eye (BAY86-5321)" (1 trials), "Aflibercept VEGF Trap-Eye (Eylea, BAY86-5321)" (1 trials), "Bevacizumab + Deferred Aflibercept Group" (1 trials) and "Deferred aflibercept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Retina Macula Specialists of Miami" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Retina Macula Specialists of Miami". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Retina Macula Specialists of Miami, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Macula Specialists of Miami, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".